Influencing factors of efficacy and long‐term use of amrubicin in patients with small cell lung cancer

BACKGROUND: Amrubicin (AMR) has become the standard of care for post‐relapse small cell lung cancer (SCLC). It has also been reported to achieve long‐term disease control in patients with good treatment response. However, the optimal patient population for whom AMR is effective and the factors assoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahara, Yutaka, Tanaka, Takuya, Ishige, Yoko, Shionoya, Ikuyo, Yamamura, Kouichi, Sakuma, Takashi, Nishiki, Kazuaki, Nakase, Keisuke, Nojiri, Masafumi, Kato, Ryo, Shinomiya, Shohei, Oikawa, Taku, Mizuno, Shiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175028/
https://www.ncbi.nlm.nih.gov/pubmed/36994539
http://dx.doi.org/10.1111/1759-7714.14871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175028/
https://www.ncbi.nlm.nih.gov/pubmed/36994539
http://dx.doi.org/10.1111/1759-7714.14871

Ejemplares similares